Benito-Sanz Sara, del Blanco Darya Gorbenko, Aza-Carmona Miriam, Magano Luis F, Lapunzina Pablo, Argente Jesús, Campos-Barros Angel, Heath Karen E
Dept. of Endocrinology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain.
Hum Mutat. 2006 Oct;27(10):1062. doi: 10.1002/humu.9456.
Léri-Weill dyschondrosteosis (LWD) is a skeletal dysplasia characterized by disproportionate short stature and Madelung deformity. Mutations or deletions of the SHOX gene have been previously identified as the main cause of LWD. We recently identified the existence of a second class of pseudoautosomal region 1 (PAR1) deletions which do not include SHOX, implicated in the etiopathogenesis of LWD. The deletions map at least 30-250 kb downstream of SHOX, are variable in size and clearly cosegregate with the LWD phenotype. In order to determine the frequency of this new type of deletions in the Spanish population we analyzed the distribution of PAR1 defects, including the screening of SHOX deletions, mutations, and PAR1 deletions downstream of SHOX, in a total of 26 LWD probands by a combination of MLPA, microsatellite analysis, SNP genotyping, dHPLC, and DNA sequencing. A molecular defect was identified in 16/26 LWD patients (61.5%): 10 PAR1 deletions downstream of SHOX, four SHOX encompassing deletions, and two SHOX mutations. No apparent phenotypic differences were observed between patients with SHOX defects and those with PAR1 deletions downstream of SHOX. In the examined cohort of Spanish LWD probands, PAR1 deletions downstream of SHOX represent the highest proportion of identified mutations (38%) compared to SHOX deletions (15%) and mutations (8%). As a consequence of our findings, the screening of this region should be included in the routine genetic testing of LWD. Also, LWD patients who tested negative for SHOX defects should be re-evaluated for PAR1 deletions downstream of SHOX.
Léri-Weill软骨发育不全症(LWD)是一种骨骼发育异常疾病,其特征为身材不成比例地矮小以及马德隆畸形。先前已确定SHOX基因突变或缺失是LWD的主要病因。我们最近发现存在第二类不包含SHOX基因的假常染色体区域1(PAR1)缺失,这与LWD的发病机制有关。这些缺失位于SHOX下游至少30 - 250 kb处,大小各异,且与LWD表型明显共分离。为了确定这种新型缺失在西班牙人群中的频率,我们通过多重连接探针扩增(MLPA)、微卫星分析、单核苷酸多态性(SNP)基因分型、变性高效液相色谱(dHPLC)和DNA测序等方法,对总共26例LWD先证者的PAR1缺陷分布进行了分析,包括SHOX缺失、突变以及SHOX下游PAR1缺失的筛查。在16/26例(61.5%)LWD患者中发现了分子缺陷:10例为SHOX下游的PAR1缺失,4例为包含SHOX的缺失,2例为SHOX突变。SHOX缺陷患者与SHOX下游PAR1缺失患者之间未观察到明显的表型差异。在所检测的西班牙LWD先证者队列中,与SHOX缺失(15%)和突变(8%)相比,SHOX下游的PAR1缺失在已鉴定的突变中占比最高(38%)。基于我们的研究结果,该区域的筛查应纳入LWD的常规基因检测中。此外,SHOX缺陷检测呈阴性的LWD患者应重新评估是否存在SHOX下游的PAR1缺失。